Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Completed 6Unknown 2Terminated 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Nasopharyngeal Carcinoma 20Prostatic Neoplasms 7Breast Neoplasms 7Head and Neck Neoplasms 6Esophageal Squamous Cell Carcinoma 6Esophageal Neoplasms 6Rectal Neoplasms 4Radiation Injuries 4Carcinoma, Squamous Cell 4Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Recurrence 2Lung Neoplasms 2Vulvar Neoplasms 1Thyroid Neoplasms 1Sinonasal undifferentiated carcinoma 1Radiation 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Obesity 1Neurotoxicity Syndromes 1Neoplasms 1

Interventions

Cisplatin 38Carboplatin 28Gemcitabine 23Docetaxel 20Radiotherapy 18Etoposide 15Paclitaxel 13Erlotinib Hydrochloride 13Vinorelbine 11Drug Therapy 11pembrolizumab 9aumolertinib 9apatinib 9Pemetrexed 9Gefitinib 9endostar protein 7Thoracic Surgery, Video-Assisted 7Blood Specimen Collection 7osimertinib 6camrelizumab 6anlotinib 6Vinblastine 6Surgical Procedures, Operative 6sintilimab 5Radiosurgery 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lung Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT05994339 2023-08-29

Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer

Laibin People's Hospital

Phase 2/3 Unknown
40 enrolled
Thoracic

Lung Neoplasms

NCT04613284 2020-11-03

RELIEF

Shanghai Chest Hospital

Phase 4 Unknown
97 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡